📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Onyvax

1.1 - Company Overview

Onyvax Logo

Onyvax

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cancer therapies that harness the immune system’s selective power to seek out and destroy tumor cells, specifically targeting cancer cells to improve effectiveness while minimizing side effects compared to conventional treatments.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Onyvax

Acambis Logo

Acambis

HQ: United Kingdom Website
  • Description: Provider of vaccine research, development and manufacturing for the prevention and treatment of infectious diseases in Europe and North America, offering ACAM2000, a smallpox vaccine for emergency-use stockpiling, and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acambis company profile →
ImmuVen Logo

ImmuVen

HQ: United States Website
  • Description: Provider of biotherapeutic discovery and drug development for infectious diseases, cancer, and autoimmune disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ImmuVen company profile →
Telesta Therapeutics Logo

Telesta Therapeutics

HQ: Canada Website
  • Description: Provider of transformative human therapeutics, focused on licensing, acquisition, development, manufacturing and commercialization of novel medicines addressing major unmet medical needs, particularly in oncology; anchor product MCNA has completed a Phase III pivotal study.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Telesta Therapeutics company profile →
Oncolytics Biotech Logo

Oncolytics Biotech

HQ: Canada Website
  • Description: Provider of oncolytic virus therapeutics for a broad range of cancers, developing Pelareorep, a nonpathogenic oncolytic virus that selectively replicates in cancer cells to generate immune responses, enhance oncology treatments, and extend patient survival.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncolytics Biotech company profile →
Apthera Logo

Apthera

HQ: United States Website
  • Description: Provider of peptide-based cancer immunotherapy solutions for the treatment of breast and prostate cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apthera company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Onyvax

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Onyvax

2.2 - Growth funds investing in similar companies to Onyvax

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Onyvax

4.2 - Public trading comparable groups for Onyvax

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Onyvax

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Onyvax

What does Onyvax do?

Onyvax is a provider of cancer therapies that harness the immune system’s selective power to seek out and destroy tumor cells, specifically targeting cancer cells to improve effectiveness while minimizing side effects compared to conventional treatments.

Who are Onyvax's competitors?

Onyvax's competitors and similar companies include Acambis, ImmuVen, Telesta Therapeutics, Oncolytics Biotech, and Apthera.

Where is Onyvax headquartered?

Onyvax is headquartered in United Kingdom.

How many employees does Onyvax have?

Onyvax has 1,000 employees 🔒.

When was Onyvax founded?

Onyvax was founded in 2010 🔒.

What sector and industry vertical is Onyvax in?

Onyvax is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Onyvax

Who are the top strategic acquirers in Onyvax's sector and industry

Top strategic M&A buyers and acquirers in Onyvax's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Onyvax?

Top strategic M&A buyers groups and sectors for Onyvax include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Onyvax's sector and industry vertical

Which are the top PE firms investing in Onyvax's sector and industry vertical?

Top PE firms investing in Onyvax's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Onyvax's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Onyvax's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Onyvax's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Onyvax include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Onyvax's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Onyvax?

The key public trading comparables and valuation benchmarks for Onyvax include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Onyvax for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Onyvax with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Onyvax's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Onyvax with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Onyvax's' sector and industry vertical?

Access recent funding rounds and capital raises in Onyvax's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Onyvax